VYNE Therapeutics Inc

NASDAQ:VYNE 11:03:12 AM EDT

1.89

+0.03 (+1.76%)

Market Cap (Intraday)	27.92M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.11 Million
Adjusted EPS	-$0.24

See more estimates

10-Day MA	$1.86
50-Day MA	$1.90
200-Day MA	$2.25

See more pivots

VYNE Therapeutics Inc Stock, NASDAQ:VYNE

685 Route 202/206 North, Suite 301, Bridgewater, New Jersey 08807

United States of America

Phone: +1.800.755.7936

Number of Employees: 10

http://www.vynetherapeutics.com

Description

VYNE Therapeutics, Inc. engages in the manufacture of pharmaceutical products. It develops and commercializes solutions using its proprietary Molecule Stabilizing Technology. Its commercial products include AMZEEQ and ZILXI. The company was founded in October 2011 and is headquartered in Bridgewater, NJ.